NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 8 மணி நேரத்திற்கு முன்இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
MAHAPEXLTD Reports Q2 FY27 Consol Net Loss of ₹10.19 Cr; Standalone PAT at ₹1.04 Cr
Maha Rashtra Apex Corporation reported its Q2 FY27 results with consolidated total income rising to ₹46.17 lakhs compared to ₹32.67 lakhs in Q2 FY26. However, consolidated net loss expanded to ₹10.19 crore for the quarter, primarily driven by a ₹10.34 crore share of loss from associates. On a standalone basis, net profit stood at ₹1.04 crore against a loss of ₹0.15 crore in Q2 FY26. Auditors issued a qualified conclusion noting unprovided delayed period interest on deposits of ₹4.06 crore cumulatively, leading to overstated profits.
உச்சம் நம்பிக்கை
என்ன மாறியதுCompany reported Q2 FY27 unaudited results, showing standalone profitability but heavy consolidated losses alongside continued auditor qualifications regarding unpaid deposit interest.
ஏன் இது முக்கியம்The company operates under a restrictive court-approved Scheme of Arrangement for asset recovery; continued heavy associate losses and pending deposit liabilities limit its financial recovery.
Consolidated Net Loss (Q2): ₹10.19 கோடிShare of Loss from Associates (Q2): ₹10.34 கோடிStandalone PAT (Q2): ₹1.04 கோடிCumulative Unprovided Deposit Interest: ₹405.88 லட்சம்Outstanding Deposits/Bonds Payable: ₹1,367.81 லட்சம்
📅 குறுகிய காலம்Weak consolidated numbers driven by associate losses and auditor reservations are likely to keep sentiment subdued in the near term.
📈 நீண்ட காலம்Limited growth potential as the company has no active expansion, its NBFC registration was cancelled by RBI in 2002, and operations are restricted to legacy asset recovery.
⚠ அபாய எச்சரிக்கைகள்
Auditor qualification regarding unprovided interest cost of ₹405.88 lakhs
Significant associate company losses (₹10.34 cr in Q2)
Cancelled NBFC license and court-mandated liability resolution
👀 கவனிக்க வேண்டியவை
Track the ongoing legal proceedings under the Scheme of Arrangement in the Karnataka High Court and the operational drag from loss-making associate companies.
₹14.09 Cr Rights Issue: Monitoring Agency confirms zero deviation in fund utilization
Maha Rashtra Apex Corporation Limited has released its first Monitoring Agency Report for the ₹14.09 crore raised via a Rights Issue in April 2026. As of June 30, 2026, the company has utilized ₹0.40 crore primarily for issue expenses, with the remaining ₹13.57 crore parked in Fixed Deposits. The core objectives include settling ₹12.25 crore in dues under a court-approved Scheme of Compromise and repaying ₹1.16 crore in advances. The Monitoring Agency, Brickwork Ratings, reported no deviations from the objects stated in the offer document.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has successfully secured ₹14.09 crore in fresh capital and has received a clean report from its monitoring agency regarding the initial handling of these proceeds.
ஏன் இது முக்கியம்For a company with a TTM revenue of only ₹2 crore, this fundraise is massive (7x annual revenue) and is critical for meeting legal obligations and settling legacy debts that have historically hindered its financial health.
Rights Issue Size: ₹14.09 கோடிIssue vs TTM Revenue: 704.5%Unutilized Funds in FDs: ₹13.57 கோடிAllocation for Scheme Dues: ₹12.25 கோடிMax FD Interest Rate: 7.00%
📅 குறுகிய காலம்Neutral; the funds are currently idle in bank deposits, providing a temporary interest income cushion but no immediate operational change.
📈 நீண்ட காலம்The fundraise is a structural step toward completing the court-approved recovery and repayment scheme, which is the company's primary business focus.
⚠ அபாய எச்சரிக்கைகள்
Dependency on legal system for execution of the Scheme of Arrangement
Non-provision of delayed interest (₹3.58 Cr) may understate actual liabilities
👀 கவனிக்க வேண்டியவை
Investors should track the actual deployment of the ₹12.25 crore towards the Scheme of Compromise by FY27, as clearing these legacy liabilities is central to the company's court-mandated restructuring.
Maha Rashtra Apex to Enter Timber Distribution via Partnership with WGW Agreen
Maha Rashtra Apex Corporation is pivoting from its legacy asset recovery focus to initiate a new business line in the marketing and distribution of Kiri/Paulownia timber. The company will serve as a channel partner for WGW Agreen Private Limited, which holds exclusive Indian rights for hybrid tissue-cultured Paulownia trees, including the Phoenix One variety. This move aims to establish a distribution network for timber traders and furniture manufacturers ahead of future plantation harvests. Given the company's current TTM revenue of just ‹2 Cr, this diversification represents a significant strategic shift, though no financial projections were provided.
நடுத்தரம் நம்பிக்கை
என்ன மாறியதுThe company is expanding beyond its restricted role of asset recovery and liability settlement into active commercial timber distribution.
ஏன் இது முக்கியம்For a company with minimal revenue (‹2 Cr) and a large net worth (‹441 Cr), a successful new business line could fundamentally re-rate the stock from a 'recovery vehicle' to an operating entity.
📅 குறுகிய காலம்The market may react to the diversification news, but immediate financial impact is unlikely as the company is currently focused on 'anticipation of availability' and network building.
📈 நீண்ட காலம்If the company successfully leverages its net worth to build a timber distribution vertical, it could provide a sustainable revenue stream to offset legacy losses, though execution in an unrelated industry is a major hurdle.
⚠ அபாய எச்சரிக்கைகள்
Execution risk in an entirely new and unrelated industry
Lack of disclosed financial terms for the channel partnership
Potential legal constraints from the existing court-approved Scheme of Arrangement
👀 கவனிக்க வேண்டியவை
Monitor for specific revenue-sharing agreements and the first set of commercial orders in the timber segment. Investors should also verify if this new business activity requires additional approvals under the existing court-mandated Scheme of Arrangement.
MAHAPEXLTD Q1 Results: Consolidated PAT at ₹3.48 Cr, Operations Remain Minimal
Maha Rashtra Apex Corporation reported a consolidated Net Profit of ₹3.48 Cr for the quarter ended June 30, 2026, a sharp decline from ₹23.86 Cr in the year-ago period. Revenue from operations remains negligible at just ₹5.95 lakhs, as the company continues to function primarily as a recovery vehicle under a court-approved Scheme of Arrangement. The bottom line was supported by 'Other Income' and share of profits from associates, including proceeds from a 7.66% share buyback by Manipal Home Finance Limited. With a TTM revenue of only ₹2 Cr against a market cap of ₹158 Cr, the company's valuation remains detached from its operational core.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company released its unaudited financial results for Q1 FY27, showing a return to profitability on a quarterly basis (vs a loss in Mar 2026) but a significant YoY decline in PAT.
ஏன் இது முக்கியம்The company is operating under a restrictive legal scheme focused on legacy asset recovery; these results confirm that its financial health is entirely dependent on non-operational recoveries and associate company performance.
Consolidated PAT (Q1): ₹3.48 கோடிRevenue from Operations (Q1): ₹5.95 லட்சம்Consolidated EPS: ₹1.23Other Income (Consolidated): ₹1.51 கோடிNet Worth: ₹441 கோடி
📅 குறுகிய காலம்The stock may remain range-bound as the results show no revival in core operations, with profits driven by one-off associate transactions.
📈 நீண்ட காலம்Limited structural growth potential as the company is legally positioned as a recovery vehicle rather than an active competitor in the finance industry.
⚠ அபாய எச்சரிக்கைகள்
Lack of core operational revenue
High dependency on legal system for asset recovery
Volatility in associate company performance
👀 கவனிக்க வேண்டியவை
Investors should focus on the progress of asset recoveries and the valuation of associate holdings rather than operational revenue, as the company is not currently engaging in new lending business.
Maha Rashtra Apex Corp Overhauls Board: Cyrus Khambata Appointed as MD for 5 Years
Maha Rashtra Apex Corporation Limited has announced a comprehensive restructuring of its leadership team effective May 26, 2026. Mr. Cyrus Khambata, a veteran with 45 years of experience in capital markets, has been appointed as the new Managing Director for a five-year term, replacing Mr. Aspi Nariman Katagara. Simultaneously, Mr. Jamsheed Minoo Panday has transitioned from Company Secretary to Executive Director, and Mr. Arvind Ganesh Mallya has been appointed as the new Compliance Officer. The board also saw the resignation of two Independent Directors and the redesignation of Mr. Kudi Bhoja Shetty to an Independent Director role.
முக்கிய அம்சங்கள்
Appointment of Mr. Cyrus Khambata as Managing Director for a 5-year term starting May 26, 2026.Resignation of Mr. Aspi Nariman Katagara (MD) and two Independent Directors citing health and personal reasons.Mr. Jamsheed Minoo Panday appointed as Executive Director; he brings 35 years of experience and 20 years with the Manipal Group.Mr. Arvind Ganesh Mallya, with 9 years of experience in corporate governance, appointed as the new Company Secretary.Mr. Kudi Bhoja Shetty redesignated as an Independent Director for a 5-year term subject to shareholder approval.
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's strategic direction under the new leadership of Mr. Cyrus Khambata, given his extensive background in capital markets. While the transition appears orderly, the high volume of board changes in a single day warrants a close watch on upcoming quarterly performance and governance standards.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Maha Rashtra Apex Reports FY26 Consolidated Loss; Appoints Cyrus Khambara as MD
Maha Rashtra Apex Corporation Limited reported a weak financial performance for FY26, with consolidated net profit swinging to a loss of ₹686.72 lakhs from a profit of ₹1,965.96 lakhs in FY25. The company underwent a significant management overhaul, appointing Cyrus Khambara as the new Managing Director following the resignation of Aspi Nariman Katgara. Standalone total income also saw a sharp decline to ₹474.13 lakhs compared to ₹791.10 lakhs in the previous year. Crucially, the statutory auditors have issued a modified opinion on the financial results, indicating potential accounting or disclosure concerns.
முக்கிய அம்சங்கள்
Consolidated net loss of ₹686.72 lakhs in FY26 vs a profit of ₹1,965.96 lakhs in FY25.Standalone total income fell by 40% year-on-year to ₹474.13 lakhs.Cyrus Khambara appointed as Managing Director for a 5-year term effective May 26, 2026.Statutory auditors M/s. H G Sarvaiya & Co. issued a modified opinion on the financial statements.Consolidated Earnings Per Share (EPS) dropped to -₹4.87 from ₹13.95 in the previous year.
👀 கவனிக்க வேண்டியவை
Investors should remain cautious given the transition to a net loss and the auditor's modified opinion. It is advisable to wait for clarity on the new management's turnaround plan and the specific reasons behind the auditor's qualifications.
Maha Rashtra Apex Corp: Trading Delay for 1.40 Crore Rights Issue Shares
Maha Rashtra Apex Corporation Limited has announced a delay in the commencement of trading for 1,40,91,896 equity shares issued through its recent Rights Issue. While listing approvals from BSE and NSE were obtained on May 06, 2026, the final trading date is pending due to a delay in receiving the credit confirmation letter from CDSL. The company is also completing procedural formalities related to forfeited shares. The management has clarified that the allotment of shares remains valid and unaffected by this administrative delay.
முக்கிய அம்சங்கள்
Allotment of 1,40,91,896 equity shares under the Rights Issue is finalized.Listing approvals from BSE and NSE were granted on May 06, 2026.Trading commencement is delayed pending CDSL credit confirmation and forfeited share formalities.Company confirms no impact on the actual allotment of the Rights Equity Shares.Revised date for commencement of trading will be intimated separately once formalities are complete.
👀 கவனிக்க வேண்டியவை
Investors who participated in the Rights Issue should monitor for the revised trading date announcement. The delay is procedural and does not impact the underlying value or validity of the allotted shares.
Maha Rashtra Apex Ltd Finalizes Allotment of 1.41 Cr Rights Issue Shares
Maha Rashtra Apex Corporation Limited has successfully completed its Rights Issue of 1,40,91,896 equity shares at Rs. 10 per share. The issue, which aimed to raise Rs. 14.09 crore, saw significant investor interest with total applications for 7,17,78,111 shares, representing an oversubscription of approximately 5.1 times. The company has now published the basis of allotment in various newspapers following the issue closure on April 30, 2026.
முக்கிய அம்சங்கள்
Issue of 1,40,91,896 equity shares at a price of Rs. 10 per share, aggregating to Rs. 14.09 croreRights entitlement ratio was 1:1 for shareholders as of the March 20, 2026 record dateReceived 2,679 applications for 7,17,78,111 shares, indicating strong demand and oversubscription428 applications for 7.37 lakh shares were rejected on technical grounds during the process
👀 கவனிக்க வேண்டியவை
Shareholders who applied for the rights issue should verify their allotment status as the basis of allotment is now finalized. The high oversubscription level is a positive signal of market confidence in the company's capital raising efforts.
Maha Rashtra Apex Allots 1.41 Crore Equity Shares via Rights Issue at Rs 10 Each
Maha Rashtra Apex Corporation Limited has successfully completed the allotment of 1,40,91,896 equity shares through a Rights Issue. The shares were issued at par value of Rs 10 each, effectively doubling the company's total paid-up equity share capital. Consequently, the paid-up capital has increased from Rs 14.09 crore to Rs 28.18 crore. This capital infusion follows the terms outlined in the Letter of Offer dated March 11, 2026.
முக்கிய அம்சங்கள்
Allotment of 1,40,91,896 fully paid-up equity shares at an issue price of Rs 10 per share.Total paid-up equity share capital doubled from 1,40,91,896 to 2,81,83,792 shares.The total paid-up capital amount increased from Rs 14,09,18,960 to Rs 28,18,37,920.The allotment was finalized in consultation with Purva Share Registry India Limited and approved by BSE.
👀 கவனிக்க வேண்டியவை
Investors should be aware of the significant equity dilution as the share count has doubled. Monitor the company's upcoming financial results to see how the newly raised capital is utilized to drive growth or improve the balance sheet.
Maha Rashtra Apex Corp Closes Rs 14.09 Crore Rights Issue
Maha Rashtra Apex Corporation Limited has officially closed its Rights Issue period on April 30, 2026. The company offered 1,40,91,896 fully paid-up equity shares at a face value of Rs. 10 each, issued at par. The total fundraise target was set at Rs. 1409.18 Lakhs. The issue was open for subscription for nearly a month, having started on April 02, 2026.
முக்கிய அம்சங்கள்
Rights Issue of up to 1,40,91,896 equity shares concluded on April 30, 2026Total issue size aggregated to approximately Rs. 1409.18 LakhsShares were offered at a face value of Rs. 10 each at parSubscription period ran from April 02, 2026, to April 30, 2026
👀 கவனிக்க வேண்டியவை
Investors should wait for the company's next update regarding the final subscription status and the basis of allotment. Monitor how the company intends to utilize the newly raised capital for its operations or debt reduction.
Maha Rashtra Apex Corp Announces 1:1 Rights Issue at ₹10 to Raise ₹14.09 Crore
Maha Rashtra Apex Corporation Limited has filed a Letter of Offer for a rights issue of up to 1,40,91,896 equity shares. The issue is priced at ₹10 per share, which is the face value, and follows a 1:1 ratio for eligible shareholders. The total fundraise is valued at approximately ₹1,409.19 lakhs. The record date for eligibility was March 20, 2026, with the subscription window open from April 2 to April 30, 2026.
முக்கிய அம்சங்கள்
Rights issue of up to 1,40,91,896 equity shares at a price of ₹10 per shareTotal capital to be raised aggregates to ₹1,409.19 lakhsRights entitlement ratio is fixed at 1:1 (one share for every one share held)Issue period is scheduled from April 2, 2026, to April 30, 2026On-market renunciation of rights entitlements is available until April 24, 2026
👀 கவனிக்க வேண்டியவை
Existing shareholders should compare the current market price with the ₹10 issue price to decide on subscription or renunciation. Investors not intending to subscribe should sell their rights entitlements by April 24 to avoid dilution without compensation.
Maha Rashtra Apex Corp Assigns ISIN INE843B20013 for Rights Entitlements
Maha Rashtra Apex Corporation Limited has finalized the International Securities Identification Number (ISIN) for its upcoming Rights Issue. The ISIN INE843B20013 has been assigned for the credit of Rights Entitlements (RE) into the demat accounts of eligible shareholders. The company has coordinated with NSDL and CDSL to ensure the REs are credited before the issue opening date. This is a procedural step following the company's decision to raise capital through a rights offering.
முக்கிய அம்சங்கள்
ISIN for Rights Entitlements identified as INE843B20013Arrangements completed with NSDL and CDSL for dematerialized creditRights Entitlements to be credited to eligible shareholders prior to the issue opening dateCompliance with SEBI Rights Issue Circulars updated as of March 9, 2026
👀 கவனிக்க வேண்டியவை
Eligible shareholders should monitor their demat accounts for the credit of Rights Entitlements and review the Rights Issue price and timeline once announced to decide on participation.
Maha Rashtra Apex Corp Sets March 20, 2026, as Record Date for Rights Issue
Maha Rashtra Apex Corporation Limited has announced March 20, 2026, as the record date for its upcoming Rights Issue of equity shares. This decision was finalized during the Board Meeting held on March 11, 2026. The record date will determine which shareholders are eligible to receive Rights Entitlements (REs) to participate in the capital raise. This move follows the company's compliance with Regulation 42 of SEBI Listing Regulations.
முக்கிய அம்சங்கள்
Record date for Rights Issue eligibility is fixed for March 20, 2026Board of Directors approved the timeline in a meeting held on March 11, 2026The issue aims to provide Rights Entitlements to existing equity shareholdersThe company is listed on both BSE (523384) and NSE (MAHAPEXLTD)
👀 கவனிக்க வேண்டியவை
Investors interested in participating in the Rights Issue must ensure they hold the company's shares before the record date. Closely monitor upcoming disclosures regarding the rights price and entitlement ratio to assess the investment's value.
Maha Rashtra Apex Corp to Raise ₹14.09 Cr via 1:1 Rights Issue at ₹10/Share
Maha Rashtra Apex Corporation has approved a Rights Issue of up to 1.41 crore equity shares at a price of ₹10 per share, which is at par with the face value. The issue follows a 1:1 ratio, allowing existing shareholders to subscribe to one new share for every share held as of the record date, March 20, 2026. The total fundraise is expected to be approximately ₹14.09 crore, effectively doubling the company's outstanding equity base if fully subscribed. The subscription window is scheduled from April 2 to April 30, 2026.
முக்கிய அம்சங்கள்
Rights Issue ratio fixed at 1:1 (one new share for every one share held)Issue price set at ₹10 per share, aggregating to a total size of ₹1,409.19 LakhsRecord date for eligibility is March 20, 2026, with the issue opening on April 2, 2026Post-issue equity capital will double to 2,81,83,792 shares assuming full subscriptionLast date for market renunciation of rights entitlements is April 29, 2026
👀 கவனிக்க வேண்டியவை
Investors should evaluate the current market price against the ₹10 issue price; if the market price is higher, they should either subscribe or sell their rights entitlements before April 29 to avoid dilution.
Maha Rashtra Apex to Finalize Rights Issue Terms on March 11; Trading Window Closed
Maha Rashtra Apex Corporation Limited has announced a trading window closure starting March 7, 2026, ahead of a crucial board meeting. The Board of Directors is scheduled to meet on March 11, 2026, to finalize the terms of a proposed Rights Issue. Key decisions will include the pricing terms, the Rights entitlement ratio, and the official schedule of the issue. The trading window will remain closed for designated persons until 48 hours after the board's decisions are disclosed to the exchanges.
முக்கிய அம்சங்கள்
Trading window for designated persons closed from March 7, 2026.Board meeting scheduled for March 11, 2026, to approve Rights Issue details.Agenda includes determining the pricing terms and Rights entitlement ratio.Approval and adoption of the Letter of Offer expected during the meeting.Trading window to reopen 48 hours after the announcement of board outcomes.
👀 கவனிக்க வேண்டியவை
Investors should closely monitor the March 11 announcement for the Rights Issue price and entitlement ratio to determine the potential for dilution. Assess the company's stated purpose for the fundraise before deciding to exercise rights.
Maha Rashtra Apex Receives Stock Exchange Approval for Rights Issue
Maha Rashtra Apex Corporation Limited has successfully obtained in-principle approval from both the National Stock Exchange (NSE) and BSE Limited for its proposed Rights Issue of equity shares. The BSE approval was granted on March 4, 2026, while the NSE approval followed on March 5, 2026. This development follows the company's initial application submitted to the exchanges on December 20, 2025. The approval marks a critical regulatory milestone in the company's efforts to raise capital through existing shareholders.
முக்கிய அம்சங்கள்
Received in-principle approval from NSE on March 5, 2026, for the Rights Issue.Received in-principle approval from BSE on March 4, 2026, for the equity issuance.Follows the initial application process initiated by the company on December 20, 2025.The fundraising is being conducted under Regulation 30 of SEBI Listing Regulations.
👀 கவனிக்க வேண்டியவை
Investors should watch for the announcement of the Rights Issue price, ratio, and record date to evaluate the potential dilution and the attractiveness of the offer.
Maha Rashtra Apex Reports Q3 Net Profit of ₹1.92 Cr; Appoints Rights Issue Monitor
Maha Rashtra Apex Corporation Limited reported a significant turnaround in Q3 FY26, posting a net profit of ₹192.35 lakhs compared to a loss of ₹19.63 lakhs in the same quarter last year. Total income surged to ₹232.57 lakhs, driven by a sharp increase in revenue from operations. However, auditors issued a qualified opinion, noting that the company failed to provide for ₹12.01 lakhs in interest costs this quarter, which overstates the reported profit. The board also appointed Brickwork Ratings as the monitoring agency for its upcoming Rights Issue.
முக்கிய அம்சங்கள்
Net Profit turned positive at ₹192.35 lakhs for Q3 FY26 against a loss of ₹19.63 lakhs in Q3 FY25.Total Income grew substantially to ₹232.57 lakhs from ₹25.16 lakhs in the year-ago period.Auditors flagged a cumulative unprovided interest liability of ₹369.71 lakhs since October 2019, overstating current profits.The company has deposited ₹1,395.75 lakhs with the Karnataka High Court regarding outstanding public deposits and bonds.Brickwork Ratings India Private Limited appointed as the monitoring agency for the proposed Rights Issue.
👀 கவனிக்க வேண்டியவை
Investors should exercise caution as the reported profits are overstated due to unprovided interest liabilities and the company's NBFC license remains cancelled by the RBI. Monitor the progress of the Rights Issue and the resolution of legal disputes regarding public deposits.
Maha Rashtra Apex Corp Files Draft Letter of Offer for Proposed Rights Issue
Maha Rashtra Apex Corporation Limited has officially filed its Draft Letter of Offer (DLOF) with the BSE and NSE on December 19, 2025. This follows the Board's decision on December 18, 2025, to raise capital through a Rights Issue of equity shares. The company is currently seeking in-principle listing approval and regulatory comments from the stock exchanges. This filing is a key procedural step before the company can finalize the issue price and entitlement ratio for shareholders.
முக்கிய அம்சங்கள்
Board approved the fundraise via Rights Issue on December 18, 2025Draft Letter of Offer (DLOF) filed with BSE and NSE on December 19, 2025Rights Issue Committee has formally approved the DLOF document for submissionCompany is awaiting in-principle listing approval from the stock exchanges
👀 கவனிக்க வேண்டியவை
Investors should monitor future disclosures for the specific Rights Issue price, ratio, and record date. Evaluate the company's stated use of proceeds in the final offer document to determine if the capital raise supports growth or debt reduction.
Maha Rashtra Apex Board Approves ₹15 Crore Rights Issue at ₹10 Per Share
Maha Rashtra Apex Corporation Limited has approved a fundraise of up to ₹15 crore through the issuance of equity shares on a rights basis. The board has fixed the issue price at ₹10 per share, which is the face value of the stock. The rights entitlement ratio is set at 15,000,000 equity shares for every 14,090,896 shares held by eligible shareholders. A Rights Issue Committee has been constituted to finalize the record date and other specific terms of the issue.
முக்கிய அம்சங்கள்
Fundraise of up to ₹15 crore through equity shares on a rights basisIssue price fixed at ₹10 per share, matching the face valueRights ratio of 15,000,000 shares for every 14,090,896 shares heldConstitution of a Rights Issue Committee to manage the process and finalize the record dateBoard meeting concluded on December 18, 2025, with immediate approval
👀 கவனிக்க வேண்டியவை
Investors should monitor for the announcement of the record date to determine eligibility for the rights. Compare the ₹10 issue price with the current market price to evaluate the potential for arbitrage or dilution impact.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
